Diabetes affects many people in the world, type 1 diabetes being a condition that can affect anyone, causing them to be on ...

Houston’s Axiom Space launched its fourth human spaceflight mission on Wednesday. One of the mission’s experiments hopes to ...

In previous treat-to-target trials, adjustments to the dose of basal insulin have been made at least weekly, according to ...

Eli Lillys Mounjaro KwikPen gains approval in India, targeting diabetes and obesity with its dual-action formula for weight ...

While many systems already pair continuous glucose monitors (CGMs) and insulin pumps, PharmaSens and SiBionics may have ...

Discover how the Axiom-4 mission to the ISS is revolutionizing diabetes treatment with groundbreaking research on glucose ...

US pharma giant Eli Lilly has secured Indian regulatory approval to market Mounjaro, its widely used diabetes and weight-loss ...

Axiom-4 astronauts are set to study insulin behaviour in microgravity, potentially transforming diabetes treatment and aiding ...

Explore how real-world evidence and biosimilars enhance insulin access and adherence, improving diabetes care and outcomes ...

During their 14-day stay aboard the orbital lab, some astronauts on the Axiom-4 mission will be wearing continuous glucose ...

The market is driven by rising diabetes prevalence worldwide and increasing adoption of wearable and connected devices ...